{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:55:58Z","timestamp":1766066158311},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/bjc.2011.326","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T20:07:08Z","timestamp":1315339628000},"page":"983-988","source":"Crossref","is-referenced-by-count":68,"title":["HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study"],"prefix":"10.1038","volume":"105","author":[{"name":"on behalf of the NHSCSP HPV Special Interest Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Patnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H C","family":"Kitchener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"issue":"4","key":"BFbjc2011326_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jnci\/djh037","volume":"96","author":"M Arbyn","year":"2004","unstructured":"Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J (2004) Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96 (4): 280\u2013293","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"BFbjc2011326_CR2","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1582-4934.2008.00631.x","volume":"13","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Martin-Hirsch P, Buntinx F, Van RM, Paraskevaidis E, Dillner J (2009) Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 13 (4): 648\u2013659","journal-title":"J Cell Mol Med"},{"issue":"3 Suppl 1","key":"BFbjc2011326_CR3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","volume":"99","author":"M Arbyn","year":"2005","unstructured":"Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J (2005) Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 99 (3 Suppl 1): S7\u2013S11","journal-title":"Gynecol Oncol"},{"issue":"6 Pt 1","key":"BFbjc2011326_CR4","first-page":"821","volume":"95","author":"C Bergeron","year":"2000","unstructured":"Bergeron C, Jeannel D, Poveda J, Cassonnet P, Orth G (2000) Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 95 (6 Pt 1): 821\u2013827","journal-title":"Obstet Gynecol"},{"key":"BFbjc2011326_CR5","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","volume":"362","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871\u20131876","journal-title":"Lancet"},{"key":"BFbjc2011326_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2334-3-23","volume":"3","author":"A Guyot","year":"2003","unstructured":"Guyot A, Karim S, Kyi MS, Fox J (2003) Evaluation of adjunctive HPV testing by hybrid capture II in women with minor cytological abnormalities for the diagnosis of CIN2\/3 and cost comparison with colposcopy. BMC Infect Dis 3: 23","journal-title":"BMC Infect Dis"},{"issue":"2","key":"BFbjc2011326_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.bjc.6605747","volume":"103","author":"R Howell-Jones","year":"2010","unstructured":"Howell-Jones R, Bailey A, Beddows S, Sargent A, de SN, Wilson G, Anton J, Nichols T, Soldan K, Kitchener H (2010) Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer 103 (2): 209\u2013216","journal-title":"Br J Cancer"},{"issue":"1","key":"BFbjc2011326_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","volume":"95","author":"HC Kitchener","year":"2006","unstructured":"Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, Sargent A, Peto J (2006) HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 95 (1): 56\u201361","journal-title":"Br J Cancer"},{"issue":"7533","key":"BFbjc2011326_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bmj.38698.458866.7C","volume":"332","author":"R Legood","year":"2006","unstructured":"Legood R, Gray A, Wolstenholme J, Moss S (2006) Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ 332 (7533): 79\u201385","journal-title":"BMJ"},{"issue":"7533","key":"BFbjc2011326_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.38701.440961.7C","volume":"332","author":"S Moss","year":"2006","unstructured":"Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H (2006) Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ 332 (7533): 83\u201385","journal-title":"BMJ"},{"issue":"Suppl 3","key":"BFbjc2011326_CR11","first-page":"S3\/1\u201310","volume":"24","author":"N Munoz","year":"2006","unstructured":"Munoz N, Castellsague X, de Gonzalez AB, Gissmann L (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24 (Suppl 3): S3\/1\u201310","journal-title":"Vaccine"},{"key":"BFbjc2011326_CR12","unstructured":"NHS (2009) Office for national statistics; cancer statistics registrations. Series MBI No.37, \n                    http:\/\/www.statistics.gov.uk\/statbase\/Product.asp?vlnk=8843"},{"issue":"9430","key":"BFbjc2011326_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","volume":"364","author":"J Peto","year":"2004","unstructured":"Peto J, Gilham C, Fletcher O, Matthews FE (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364 (9430): 249\u2013256","journal-title":"Lancet"},{"issue":"7291","key":"BFbjc2011326_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.322.7291.893","volume":"322","author":"G Rebello","year":"2001","unstructured":"Rebello G, Hallam N, Smart G, Farquharson D, McCafferty J (2001) Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ 322 (7291): 893\u2013894","journal-title":"BMJ"},{"issue":"2","key":"BFbjc2011326_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/JCM.00896-09","volume":"48","author":"A Sargent","year":"2010","unstructured":"Sargent A, Bailey A, Turner A, Alimonte M, Gilham C, Baysson H, Peto J, Roberts C, Thomson C, Desai M, Mather J, Kitchener H (2010) Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus; data from the ARTISTIC trial. J Clin Microbiol 48 (2): 554\u2013558","journal-title":"J Clin Microbiol"},{"issue":"8","key":"BFbjc2011326_CR16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/bjc.1996.196","volume":"73","author":"PD Sasieni","year":"1996","unstructured":"Sasieni PD, Cuzick J, Lynch-Farmery E (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73 (8): 1001\u20131005","journal-title":"Br J Cancer"},{"issue":"11","key":"BFbjc2011326_CR17","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","volume":"17","author":"A Szarewski","year":"2008","unstructured":"Szarewski A, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter P, Lyons D, Cuzick J (2008) Comparison of predictors for high-grade cervical intraepithelial neoplasia in woman with abnormal smears. Cancer Epidemiol Biomarkers Prev 17 (11): 3033\u20133042","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFbjc2011326_CR18","doi-asserted-by":"publisher","first-page":"b2549","DOI":"10.1136\/bmj.b2549","volume":"339","author":"TOMBOLA Group","year":"2009","unstructured":"TOMBOLA Group (2009a) Biopsy and selective recall compared with immediate large loop excision in management of women with low grade cervical cytology referred for colposcopy: mulitcentre randomised controlled trial. BMJ 339: b2549","journal-title":"BMJ"},{"key":"BFbjc2011326_CR19","doi-asserted-by":"publisher","first-page":"b2546","DOI":"10.1136\/bmj.b2546","volume":"339","author":"TOMBOLA Group","year":"2009","unstructured":"TOMBOLA Group (2009b) Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 339: b2546","journal-title":"BMJ"},{"key":"BFbjc2011326_CR20","doi-asserted-by":"publisher","first-page":"b2549","DOI":"10.1136\/bmj.b2549","volume":"339","author":"TOMBOLA Group","year":"2009","unstructured":"TOMBOLA Group (2009c) Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 339: b2549","journal-title":"BMJ"},{"key":"BFbjc2011326_CR21","volume-title":"International Agency for Research on Cancer, World Health Organisation","author":"J Waterhouse","year":"1976","unstructured":"Waterhouse J, Muir C, Correa P, Powel J eds. (1976) Cancer incidence in five continents. In International Agency for Research on Cancer, World Health Organisation, Vol. III, IARC Scientific Publication No 15: Lyon"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011326","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:02:57Z","timestamp":1684414977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["BFbjc2011326"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.326","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"type":"print","value":"0007-0920"},{"type":"electronic","value":"1532-1827"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}